Results 161 to 170 of about 7,614 (192)
Quantification of Hyperreflective Foci in Age-related Macular Degeneration by Polarization-Sensitive OCT. [PDF]
Terao R +8 more
europepmc +1 more source
The Correlation of Optical Coherence Tomography Angiography Parameters With Serum Vascular Endothelial Growth Factor-A (VEGF-A) Levels in Diabetic Macular Edema. [PDF]
Sodhi PK +8 more
europepmc +1 more source
From Observation to Surgery: A Review of Literature and an Updated Algorithm for Acquired Retinoschisis and Schisis-Detachment. [PDF]
Scampoli A, Caporossi T.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Photo-induced damage to neurosensory retinal cells after preliminary X-Ray irradiation
Bulletin of Experimental Biology and Medicine, 2000Preliminary X-ray irradiation (5 Gr) enhances damages to neurosensory retinal cells by visible light (3500 lx, 48 h) in rats. This combined treatment caused early destruction of the external and preterminal processes, karyopyknosis and karyolysis of about 30% neurosensory cells followed by focal destruction of the corresponding retinal layers.
S V, Logvinov, A V, Potapov
openaire +2 more sources
Current Eye Research, 2005
To evaluate the toxicity of indocyanine green (ICG) in combination with light.Human retinal pigment epithelial cells (ARPE-19) and rat neurosensory retinal cells (R28) were treated with four different concentrations of ICG in combination with light exposure.
Raja, Narayanan +6 more
openaire +2 more sources
To evaluate the toxicity of indocyanine green (ICG) in combination with light.Human retinal pigment epithelial cells (ARPE-19) and rat neurosensory retinal cells (R28) were treated with four different concentrations of ICG in combination with light exposure.
Raja, Narayanan +6 more
openaire +2 more sources
Retina, 2006
To evaluate the short-term in vitro safety of bevacizumab (Avastin) in human retinal pigment epithelial (ARPE-19), rat neurosensory retinal (R28), and human microvascular endothelial (HMVECad) cells.ARPE-19 and R28 cells were treated with 0.125 mg/mL, 0.25 mg/mL, 0.50 mg/mL, and 1 mg/mL of bevacizumab for 2, 6, and 24 hours.
Saurabh, Luthra +11 more
openaire +2 more sources
To evaluate the short-term in vitro safety of bevacizumab (Avastin) in human retinal pigment epithelial (ARPE-19), rat neurosensory retinal (R28), and human microvascular endothelial (HMVECad) cells.ARPE-19 and R28 cells were treated with 0.125 mg/mL, 0.25 mg/mL, 0.50 mg/mL, and 1 mg/mL of bevacizumab for 2, 6, and 24 hours.
Saurabh, Luthra +11 more
openaire +2 more sources

